{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:17:08Z","timestamp":1761016628436},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ijantimicag.2007.08.024","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T08:25:17Z","timestamp":1196497517000},"page":"290","source":"Crossref","is-referenced-by-count":12,"title":["Seizures associated with ertapenem"],"prefix":"10.1016","volume":"31","author":[{"given":"Catherine","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene Christine","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Ananth","family":"Tambyah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeoh Siang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.08.024_bib1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1528-1157.2001.34701.x","article-title":"Seizures in the critically ill: the role of imipenem","volume":"42","author":"Koppel","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijantimicag.2007.08.024_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1345\/aph.1E421","article-title":"Ertapenem-associated seizures in a peritoneal dialysis patient","volume":"39","author":"Seto","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2007.08.024_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/505304","article-title":"History of cerebrovascular events: a relative contraindication to ertapenem","volume":"43","author":"Saidel-Odes","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.08.024_bib4","unstructured":"Prescribing information. Invanz (ertapenem). Whitehouse Station, NJ: Merck & Co.; 2004."},{"key":"10.1016\/j.ijantimicag.2007.08.024_bib5","unstructured":"Prescribing information. Merrem (meropenem). Wilmington, DE: AstraZeneca Pharmaceuticals; 2004."},{"key":"10.1016\/j.ijantimicag.2007.08.024_bib6","unstructured":"Prescribing information. Primaxin (imipenem and cilastatin sodium). Whitehouse Station, NJ: Merck & Co.; 2003."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T14:20:50Z","timestamp":1546438850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907004633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0924857907004633"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.08.024","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}